Global Multiple Sclerosis (MS) Therapeutics Market 2012-2016

世界の多発性硬化症(MS)市場動向(2012-2016)

◆タイトル:Global Multiple Sclerosis (MS) Therapeutics Market 2012-2016
◆商品コード:IRTNTR2566
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2013年9月6日
◆ページ数:55
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥313,600見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥392,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"世界の多発性硬化症(MS)市場動向(2012-2016)"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、主要地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況等の情報をお届けいたします。

TechNavio’s analysts forecast the Global Multiple Sclerosis (MS) Therapeutics market to grow at a CAGR of 3.16 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rising diagnosis and treatment rates. The Global MS Therapeutics market has also been witnessing the emergence of biomarkers. However, the lack of therapies available to manage the progression of the disease could pose a challenge to the growth of this market.
TechNavio’s report, the Global Multiple Sclerosis (MS) Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global MS Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Bayer HealthCare AG, Biogen Idec Inc., Merck Serono SA, Novartis AG, and Teva Pharmaceutical Industries Ltd.
The other vendors mentioned in this report are AB Science, Abbvie Inc., Active Biotech AB, Astra Zeneca plc, Glaxo Smith Kline plc, Glenmark Pharmaceuticals Ltd., Hoffmann-La Roche Inc., and Sanofi SA.
Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Market Landscape
06.1 Global MS Market
Market Size and Forecast
06.2 MS Market in the US
Market Size and Forecast
06.3 MS Market in Europe
Market Size and Forecast
06.4 Five Forces Analysis
07. Geographical Segmentation
08. Rate of Incidence and Prevalence
09. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
15.1 Bayer HealthCare AG
Business Overview
Key Information
SWOT Analysis
15.2 Biogen Idec Inc.
Business Overview
Key Information
SWOT Analysis
15.3 Merck Serono SA
Business Overview
Key Information
SWOT Analysis
15.4 Novartis AG
Business Overview
Key Information
SWOT Analysis
15.5 Teva Pharmaceutical Industries Ltd.
Business Overview
Key Information
SWOT Analysis
16. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global MS Market 2012-2016 (US$ billion)
Exhibit 3: MS Market in the US 2012-2016 (US$ billion)
Exhibit 4: MS Market in Europe 2012-2016 (US$ billion)
Exhibit 5: Global MS Market by Geographical Segmentation 2012
Exhibit 6: Global MS Market by Vendor Segmentation 2012
Exhibit 7: Business Segmentation of Bayer HealthCare AG
Exhibit 8: Business Segmentation of Merck Serono SA
Exhibit 10: Business Segmentation of Novartis AG
Exhibit 12: Business Segmentation of Teva Pharmaceuticals Industries Ltd.



【掲載企業】

Bayer HealthCare AG, Biogen Idec Inc., Merck Serono SA, Novartis AG, and Teva Pharmaceutical Industries Ltd., AB Science, Abbvie Inc., Active Biotech AB, Astra Zeneca plc, Glaxo Smith Kline plc, Glenmark Pharmaceuticals Ltd., Hoffmann-La Roche Inc., and Sanofi SA.

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[世界の多発性硬化症(MS)市場動向(2012-2016)] (Global Multiple Sclerosis (MS) Therapeutics Market 2012-2016 / IRTNTR2566)販売に関する免責事項
[世界の多発性硬化症(MS)市場動向(2012-2016)] (Global Multiple Sclerosis (MS) Therapeutics Market 2012-2016 / IRTNTR2566)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆